"The National Institutes of Health has Awarded AGT a Competitive SBIR Phase I Contract"
September, 2000.
The National Institutes of Health has awarded AGT a competitive SBIR Phase I Contract to research the applicability of using its patented OAUGDP technology to eradicate tenacious biofilms on medically important surfaces.